GlassScriptPhysician profile
Nasir Malik
NPI 1770831984
$2,497.46
in general payments reported to CMS, 2019-2025
17 companies · $1,431 in 2025
The $1,431 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.21 · 2020: $76.43 · 2022: $96.48 · 2023: $346 · 2024: $534 · 2025: $1,431.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,236 · Education: $74.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,236.48 |
| Education | $74.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,091.92 | 2019-2025 | Tezspire, Fasenra, Breztri |
| Glaxosmithkline, LLC. | $334.16 | 2023-2025 | Nucala, Trelegy Ellipta |
| Philips North America LLC | $219.62 | 2023-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Lilly USA, LLC | $135.00 | 2025 | Zepbound |
| Pulmonx Corporation | $130.81 | 2023-2025 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Zephyr Endobronchial Valve |
| United Therapeutics Corporation | $91.87 | 2025 | Tyvaso, Tyvaso |
| Genzyme Corporation | $78.39 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $76.99 | 2022-2025 | Dupixent |
| Mallinckrodt Hospital Products INC. | $76.43 | 2020 | |
| Sanofi-Aventis U.S. LLC | $57.48 | 2025 | |
| Baxter Healthcare | $47.29 | 2023-2024 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Takeda Pharmaceuticals U.S.A., INC. | $41.96 | 2025 | Aralast |
| Jazz Pharmaceuticals INC. | $32.37 | 2025 | |
| Amgen INC. | $30.88 | 2023-2025 | Tezspire |
| Monaghan Medical Corporation | $19.10 | 2023 | Aeroeclipse |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $17.38 | 2025 | Brinsupri |
| Inogen, INC. | $15.81 | 2023 | Inogen One G3 Oxygen Concentrator |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nasir Malik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.